
Funded by The National Institute of Biomedical Imaging and Bioengineering
We design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management.
What is Precision Medicine?
The Precision Medicine initiative aims to shift away from a generic treatment approach to customizing medications for individuals. This tailored approach ensures that patients receive the most effective and safe treatments by targeting the specific characteristics of their illness.
CBM² is contributing to the Precision Medicine initiative by developing advanced tools that can rapidly deliver crucial diagnostic and prognostic information, overcoming current testing limitations.


CBM² Tool Development for Precision Medicine
We are producing a suite of mixed-scale devices (i.e., task-specific modules) that can be integrated into a fluidic motherboard to produce systems, which can process liquid biopsy samples, for a broad range of clinical applications with a Precision Medicine focus. The attributes of our systems are:
•Devices made from thermoplastics via injection molding with mixed-scales structures (mm → nm)
•Extensive infrastructure for making and characterizing device architecture and material properties
•Ability to change the surface chemistry of the plastic to match the application (covalent attachment of biologics, alter surface wettability, etc.).
•Toolbox of devices for the selection of liquid biopsy markers from clinical samples (blood, saliva, urine, etc.)
•Label-free and single-molecule analysis device (X-ToF) for determining the molecular structure of biopolymers, such as DNA, RNA, and proteins.
•Modular systems with an automated workflow to accept a clinical sample, enrich the required liquid biopsy marker, and secure molecular information on even low abundant markers.
•Ability of integrated system to search of epigenetic, epitranscriptomic, and post-translational modifications in DNA, RNA, and proteins, respectively.
Our Resources
CBM² Stories

Soper Group Hosts Tour at Gray-Little Hall During Economic Development Group Visit

University of Kansas drives $7.8 billion economic impact in Kansas, study shows

Foundation Distinguished Professor Steven A. Soper named April 2025 Sutton Family Research Impact Award recipient
The Department of Chemistry congratulates Distinguished Professor Steven A. Soper on receiving the April 2025 Sutton Family Research Impact Award! ...












